Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | |
2 | Current Medicinal Chemistry | journal | 0.934 Q1 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.706 Q2 | 133 | 240 | 735 | 21755 | 2287 | 620 | 2.65 | 90.65 | |
4 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | |
5 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | |
7 | Current Alzheimer Research | journal | 1.032 Q2 | 103 | 122 | 371 | 8520 | 1392 | 355 | 3.35 | 69.84 | |
8 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q2 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | |
10 | Current Protein and Peptide Science | journal | 0.750 Q2 | 96 | 106 | 361 | 10103 | 947 | 326 | 2.75 | 95.31 | |
11 | Current Organic Chemistry | journal | 0.368 Q3 | 112 | 136 | 503 | 15186 | 946 | 467 | 1.92 | 111.66 | |
12 | Current Stem Cell Research and Therapy | journal | 0.802 Q2 | 63 | 74 | 232 | 7195 | 778 | 215 | 3.24 | 97.23 | |
13 | Current Drug Delivery | journal | 0.449 Q2 | 72 | 76 | 320 | 5298 | 764 | 303 | 2.63 | 69.71 | |
14 | Current Cancer Drug Targets | journal | 0.972 Q1 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | |
15 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.518 Q3 | 63 | 172 | 255 | 11632 | 720 | 247 | 2.85 | 67.63 | |
16 | Current Vascular Pharmacology | journal | 0.806 Q2 | 69 | 76 | 225 | 5973 | 643 | 197 | 2.27 | 78.59 | |
17 | Medicinal Chemistry | journal | 0.308 Q3 | 50 | 92 | 242 | 4815 | 575 | 238 | 2.29 | 52.34 | |
18 | Emirates Journal of Food and Agriculture | journal | 0.304 Q3 | 43 | 106 | 365 | 4382 | 498 | 363 | 1.12 | 41.34 | |
19 | Current Organic Synthesis | journal | 0.292 Q4 | 55 | 68 | 263 | 2831 | 496 | 255 | 1.92 | 41.63 | |
20 | Current Bioinformatics | journal | 0.306 Q3 | 38 | 116 | 206 | 6169 | 482 | 192 | 2.82 | 53.18 | |
21 | Current Diabetes Reviews | journal | 0.631 Q3 | 68 | 111 | 177 | 7003 | 462 | 167 | 2.21 | 63.09 | |
22 | Current Genomics | journal | 0.823 Q3 | 77 | 64 | 172 | 4501 | 462 | 152 | 2.04 | 70.33 | |
23 | Letters in Drug Design and Discovery | journal | 0.223 Q3 | 37 | 144 | 426 | 5796 | 461 | 413 | 1.11 | 40.25 | |
24 | Open Dentistry Journal | journal | 0.428 Q3 | 37 | 107 | 278 | 3321 | 452 | 270 | 1.42 | 31.04 | |
25 | Current Gene Therapy | journal | 0.704 Q2 | 80 | 38 | 129 | 2994 | 406 | 113 | 3.25 | 78.79 | |
26 | Current Neurovascular Research | journal | 0.592 Q3 | 60 | 86 | 165 | 3568 | 388 | 153 | 1.86 | 41.49 | |
27 | Combinatorial Chemistry and High Throughput Screening | journal | 0.292 Q3 | 70 | 109 | 272 | 4931 | 367 | 251 | 1.15 | 45.24 | |
28 | Current Nanoscience | journal | 0.285 Q3 | 52 | 88 | 212 | 6490 | 351 | 203 | 1.74 | 73.75 | |
29 | Current Analytical Chemistry | journal | 0.289 Q4 | 38 | 117 | 211 | 6009 | 346 | 200 | 1.74 | 51.36 | |
30 | Letters in Organic Chemistry | journal | 0.180 Q4 | 33 | 122 | 394 | 4278 | 324 | 373 | 0.75 | 35.07 | |
31 | Current Cardiology Reviews | journal | 0.815 Q2 | 58 | 59 | 111 | 2903 | 305 | 102 | 2.24 | 49.20 | |
32 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | |
33 | Mini-Reviews in Organic Chemistry | journal | 0.283 Q4 | 43 | 62 | 146 | 4990 | 291 | 136 | 2.15 | 80.48 | |
34 | Current Medical Imaging | journal | 0.179 Q4 | 37 | 141 | 293 | 7127 | 286 | 284 | 0.96 | 50.55 | |
35 | Current Molecular Pharmacology | journal | 0.717 Q2 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | |
36 | Current Bioactive Compounds | journal | 0.269 Q2 | 31 | 133 | 162 | 6765 | 246 | 156 | 1.31 | 50.86 | |
37 | Current Pediatric Reviews | journal | 0.736 Q2 | 33 | 40 | 103 | 2344 | 240 | 92 | 2.46 | 58.60 | |
38 | Current Radiopharmaceuticals | journal | 0.586 Q2 | 32 | 23 | 92 | 922 | 228 | 84 | 3.09 | 40.09 | |
39 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.891 Q1 | 29 | 0 | 64 | 0 | 218 | 60 | 3.34 | 0.00 | |
40 | Current Rheumatology Reviews | journal | 0.492 Q3 | 29 | 52 | 117 | 2048 | 216 | 114 | 1.88 | 39.38 | |
41 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 28 | 95 | 1263 | 209 | 89 | 2.51 | 45.11 | ||
42 | Current Pharmaceutical Analysis | journal | 0.210 Q3 | 27 | 137 | 241 | 5109 | 206 | 239 | 0.86 | 37.29 | |
43 | Reviews on Recent Clinical Trials | journal | 0.509 Q3 | 35 | 44 | 130 | 1929 | 200 | 115 | 1.47 | 43.84 | |
44 | Current Nutrition and Food Science | journal | 0.221 Q3 | 32 | 164 | 176 | 8379 | 192 | 171 | 0.99 | 51.09 | |
45 | Clinical Practice and Epidemiology in Mental Health | journal | 0.692 Q2 | 58 | 26 | 80 | 1054 | 189 | 69 | 2.55 | 40.54 | |
46 | Current Drug Discovery Technologies | journal | 0.319 Q3 | 49 | 70 | 105 | 4231 | 180 | 101 | 1.78 | 60.44 | |
47 | Current Drug Safety | journal | 0.334 Q3 | 41 | 36 | 117 | 1064 | 177 | 114 | 1.79 | 29.56 | |
48 | Current Aging Science | journal | 0.495 Q3 | 42 | 20 | 79 | 1269 | 170 | 74 | 1.85 | 63.45 | |
49 | Open Civil Engineering Journal | journal | 0.249 Q3 | 21 | 36 | 162 | 1157 | 170 | 156 | 1.28 | 32.14 | |
50 | Infectious Disorders - Drug Targets | journal | 0.322 Q3 | 61 | 122 | 116 | 4449 | 166 | 112 | 1.47 | 36.47 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®